Rebekka Vogtmann

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 3

Top Topics

Multidrug Resistant

Tyrosine Kinase

Top Venues

Oxidative medicine and cellular longevity

Science advances

Hypertension (Dallas, Tex. : 1979)

This page only lists publications with an associated author ORCID identifier.

Publications

Rebekka Vogtmann, Lilo Valerie Burk, Meray Serdar, Rainer Kimmig, Ivo Bendix, Alexandra Gellhaus
Systemic Maternal Human sFLT1 Overexpression Leads to an Impaired Foetal Brain Development of Growth-Restricted Foetuses upon Experimental Preeclampsia. Oxidative medicine and cellular longevity 2022 (2022)
Maximilian Lassi, Archana Tomar, Gemma Comas-Armangue, Rebekka Vogtmann, Dorieke J Dijkstra, David Corujo, Raffaele Gerlini, Jonatan Darr, Fabienne Scheid, Jan Rozman, Juan Antonio Aguilar-Pimentel, Omry Koren, Marcus Buschbeck, Helmut Fuchs, Susan Marschall, Valérie Gailus-Durner, Martin Hrabě de Angelis, Torsten Plösch, Alexandra Gellhaus, Raffaele Teperino
Disruption of paternal circadian rhythm affects metabolic health in male offspring via nongerm cell factors. Science advances 7 (22) (2021)
Rebekka Vogtmann, Jacqueline Heupel, Florian Herse, Mahsa Matin, Henning Hagmann, Ivo Bendix, Kristin Kräker, Ralf Dechend, Elke Winterhager, Rainer Kimmig, Angela Köninger, Alexandra Gellhaus
Circulating Maternal sFLT1 (Soluble fms-Like Tyrosine Kinase-1) Is Sufficient to Impair Spiral Arterial Remodeling in a Preeclampsia Mouse Model. Hypertension (Dallas, Tex. : 1979) 78 (4) (2021)